Ep.136 – Convenience vs. Care: Rethinking IV Push Cefepime in Critically Ill Pseudomonas Patients

Ep.137 – Stewardship in Action: Poster Highlights from the MAD-ID & SIDP 2026 Annual Meeting

EPISODE NOTES In this episode of the DASON Digest, DASON Clinical Pharmacist Liaison, Dr. Jeannette Bouchard, highlights key posters and clinical pearls from the MAD-ID and SIDP 2026 Annual Meeting, including oral antibiotic transitions, Bayesian vancomycin dosing, renal dose adjustments in septic shock, personalized antibiograms, and greener antimicrobial stewardship practices. For more information about DASON, please visit: https://dason.medicine.duke.edu/ [https://dason.medicine.duke.edu/]

Ep.136 – Convenience vs. Care: Rethinking IV Push Cefepime in Critically Ill Pseudomonas Patients

EPISODE NOTES In this episode of the DASON Digest, we discuss Chris Bland's study on IV push cefepime for Pseudomonas aeruginosa and the implications of these findings. The article can be found here: https://pubmed.ncbi.nlm.nih.gov/41166592/ [https://pubmed.ncbi.nlm.nih.gov/41166592/] For more information about DASON, please visit: https://dason.medicine.duke.edu/ [https://dason.medicine.duke.edu/]

Ep.135 – Bugging Out: Antimicrobial Updates in Sepsis Care

EPISODE NOTES Join ID Pharmacy Resident Paul Puccio as he speaks with Dr. Arielle Cohen, an ID Fellow at Duke University, is about the antimicrobial updates in the 2026 Surviving Sepsis Campaign guidelines. They focus on timing of antibiotic initiation, antimicrobial coverage, and rapid diagnostic tests and what this means for the treatment of sepsis and septic shock. The guidelines can be viewed here: https://pubmed.ncbi.nlm.nih.gov/41870560/ [https://pubmed.ncbi.nlm.nih.gov/41870560/] For more information about DASON, please visit: https://dason.medicine.duke.edu/ [https://dason.medicine.duke.edu/]

Ep.134 – When Antibiotics Get Lost in Transition: Errors Moving from Hospital to Skilled Nursing Facility

EPISODE NOTES In this episode of the DASON Digest, we discuss Dr. Amy Kang’s study on antimicrobial transition errors from hospitals to skilled nursing facilities, highlighting that nearly one-third of patients experience errors and why stewardship efforts must extend beyond hospital discharge to improve continuity, safety, and infection outcomes. The article from the episode can be viewed here: https://pubmed.ncbi.nlm.nih.gov/41852555/ [https://pubmed.ncbi.nlm.nih.gov/41852555/] For more information about DASON, please visit: https://dason.medicine.duke.edu/ [https://dason.medicine.duke.edu/]

Ep.133 – Beyond the Cardinal Symptoms: Evaluating the Latest Antibiotic COPDE Treatment Criteria

EPISODE NOTES Join DASON Clinical Pharmacist Liaison Dr. Jeannette Bouchard and Dr. Rey Perez as they discuss the 2026 GOLD guideline updates regarding antibiotic use in COPD exacerbations. Together, they explore the clinical implications of antibiotic treatment indications—including prior positive sputum cultures—and discuss practical strategies for antimicrobial stewardship teams to reduce unnecessary empiric prescribing at the point of admission. The document for this episode can be viewed here: https://goldcopd.org/wp-content/uploads/2026/01/GOLD-REPORT-2026-v1.3-8Dec2025_WMV2.pdf [https://goldcopd.org/wp-content/uploads/2026/01/GOLD-REPORT-2026-v1.3-8Dec2025_WMV2.pdf] For more information about DASON, please visit: https://dason.medicine.duke.edu/ [https://dason.medicine.duke.edu/]